image description

Ching-Yang Lin

Partner

Ching-Yang Lin

Partner
Hong Kong +852-2826-8688+852-2826-8688 +852-2522-2280+852-2522-2280
[email protected]
Ching-Yang Lin is a member of Sullivan & Cromwell’s general practice group. His practice focuses on securities offerings and exchange listings, and public and private mergers and acquisitions transactions. Mr. Lin advised a number of clients in Greater China on SEC-registered and non-registered securities offerings, as well as cross-border M&As. He has also advised clients on ongoing regulatory and reporting requirements.

SELECTED REPRESENTATIONS

Securities Offering and other Corporate Finance
  • Advised the underwriters of Mulsanne Group in its $112.6 million initial public offering and listing on the Hong Kong Stock Exchange
  • Advised IntelliCentrics Global Holdings on its $55.4 million initial public offering and listing on the Hong Kong Stock Exchange
  • Advised JP Morgan as bookrunner in Taiwan Cement Corporation’s $400 million overseas unsecured convertible bonds due 2023
  • Advised an existing shareholder of BeiGene and a cornerstone investor in BeiGene, Ltd.’s $903 million global offering and second primary listing on the Hong Kong Stock Exchange
  • Advised JP Morgan, Morgan Stanley and Merrill Lynch as joint bookrunners on Taiwan Cement Corporation’s $549 million offering of global depositary receipts under Rule 144A and Regulation S
  • Advised Goldman Sachs on the $64.4 million global offering and listing on the Hong Kong Stock Exchange of AK Medical Holdings Limited
  • Advised Bank of America Merrill Lynch, China International Capital Corporation and Credit Suisse on Foxconn Group’s spin-off and listing of its subsidiary Foxconn Interconnect Technology  on the Hong Kong Stock Exchange
  • Advised New Century Healthcare Holding Co. Limited on its $123 million global offering and listing on the Hong Kong Stock Exchange
  • Advised China Oriental in its global cash tender offer and exit consent in relation to the repurchase of its $111  million outstanding senior notes due 2017
  • Advised Morgan Stanley and CLSA on the $244 million global offering and listing on the Hong Kong Stock Exchange of Regina Miracle
  • Advised the underwriters of Universal Medical Services & Health Management on the $514 million global offering and listing on the Hong Kong Stock Exchange
  • Advised UBS and China Merchants Securities on the $1.1 billion global offering and listing on the Hong Kong Stock Exchange of Fuyao Glass Corporation
  • Advised Goldman Sachs and Deutsche Bank on the $220 million global offering and listing on the Hong Kong Stock Exchange of Phoenix Healthcare Group
  • Advised Goldman Sachs , Deutsche Bank, Credit Suisse and China International Capital Corporation in connection with Shanghai Pharmaceuticals Holding Co., Ltd.’s $2 billion global offering and listing on the Hong Kong Stock  Exchange of H shares
  • Advised Nirvana Asia in its $261 million Hong Kong IPO and Rule 144A placement of shares
  • Advised the underwriters to Ozner Water International in its $168 million initial public offering and listing in Hong Kong with Rule 144A offering in the U.S.
  • Advised selling shareholders in Alibaba Group’s $25 billion initial public offering and listing on the  New York Stock Exchange
  • Advised China Merchants Bank on its $5.7 billion rights offering
  • Advised the underwriters led by China International Capital Corporation, Credit Suisse, Deutsche Bank, Goldman Sachs and HSBC, on the $3.1 billion IPO and listing in Hong Kong of the People’s Insurance Company (Group) of China Limited
  • Advised Citigroup, Deutsche Bank, Goldman Sachs and Morgan Stanley as the joint global coordinators to AIA Group Limited on its $20.5 billion initial public offering of ordinary shares
  • Advised Morgan Stanley as the sole bookrunner to China Zenix Auto International Limited on its SEC-registered offering of American depositary shares
  • Advised SITC International Holdings  Company Limited on its $400 million global offering and listing on the Hong Kong Stock Exchange of ordinary shares
  • Advised Alibaba.com Limited on its $1.7 billion global offering and listing on the Hong Kong Stock Exchange of ordinary shares
  • Advised a Korean conglomerate on the restructuring  of its outstanding debts
  • Advising underwriters to debt and warrant offerings under Rule 144A and Regulation S by United Mexican States in the United States
  • Advised ChipMOS Technologies (Bermuda) Ltd. on securities offerings, other capital market transactions and mergers and acquisitions, and in connection with ongoing compliance with U.S. securities laws, NASDAQ rules and corporate governance matters
Mergers & Acquisitions
  • Advised Suning.com in its $1.5 billion sale of ordinary shares of Alibaba Group through Goldman Sachs
  • Advised an affiliate of Bitmain Technologies Limited as the lead investor in an $110 million Series E equity investment in Circle Internet Financial Limited
  • Advised Spirit AeroSystems in its disposal of equity interest in Taikoo Spirit AeroSystems (Jinjiang) Composite Co., Ltd., a sino-foreign joint venture established by Spirit, HAECO and certain other shareholders, to Hong Kong Aircraft Engineering Company Limited (HAECO)
  • Advised Pou Chen Corporation in its proposed $1.39 billion privatization of its indirect Hong Kong-listed subsidiary Pou Sheng International (Holdings) Limited by way of a scheme of arrangement
  • Advised Taiwan Cement Corporation and TCC International Limited in their privatization of TCC International Holdings Limited (TCCIH) by way of a scheme of arrangement, valuing TCCIH at $2.55 billion. The first ever share swap between Hong Kong and Taiwan listed companies.
  • Advising a China-based PE fund in acquiring the controlling interest in a U.S.-listed, Canada-headquartered company (ongoing)
  • Advised Anheuser-Busch InBev on its $1.6 billion sale of SAB Miller’s 49% interest in China Resources Snow Breweries to China Resources Beer
  • Advised Taiwan Cement Corporation on its acquisition of minority interest in TCC International  Holdings 
  • Advised  the financial advisor of HomeInns on its $1.12 billion going private transaction
  • Advised a large-scale family office on its various tranches of financing
  • Advised a consortium led by Ally Bridge Group Capital Partners in a definitive agreement and plan of merger with WuXi PharmaTech (Cayman) Inc., pursuant to which the consortium will acquire WuXi PharmaTech at approximately $3.3 billion – one of the largest going-private transactions, as well as one of the largest leveraged buyouts, for a Chinese business
  • Advised the special committee of Shanda Games on its $1.9 billion going private transaction
  • Advised Suning Commerce Group in its RMB10 billion acquisition financing
  • Advised Suning Commerce Group in its sale of a 19.9% stake to Alibaba for $4.3 billion
  • Advised Suning Commerce Group in its acquisition of $2.15 billion worth of shares in Alibaba
  • Advised a large-scale family office on its formation and $1.9 billion financing
  • Advised Credit Suisse, the financial advisor to Bitauto Holdings Limited, on the $1.3 billion investment by JD.com, Inc. and Tencent ‎Holdings Limited in Bitauto
  • Advised a consortium of investors, comprising the Carlyle Group, CITIC Capital Partners, CDH Investments, China Everbright Limited and FountainVest Partners, on the $3.7 billion going-private of Focus Media Holding Ltd.
  • Advised CST Mining Group on a $505 million sale of its 70% stake in the Mina Justa copper mine in Peru to the Minsur S.A., part of the Breca Group of Peru
  • Advised ASE Test Limited on its going-private transaction with Advanced Semiconductor Engineering, Inc.
  • Advised a PRC-based PE Fund on taking private of Asia-Info Linkage (did not close)
  • Advised Anheuser-Busch InBev NV/SA on its $1.8 billion sale of stakes in Oriental Brewery Co., Ltd. to Kohlberg Kravis Roberts & Co.
  • Advised Goldman Sachs on its acquisition of Macquarie IMM Fund Management Company in Korea
  • Advised American Express Company on the sale of its 638 million ordinary H shares of Industrial and Commercial Bank of China
  • Advised Goldman Sachs Group, Inc. on the sale of its 3 billion ordinary H shares of Industrial and Commercial Bank of China
  • Advised Goldman Sachs PIA on its proposed pre-IPO investment in a Taiwanese TV shopping channel operator
  • Advised Goldman Sachs PIA on its proposed pre-IPO investment in convertible debt of a Taiwanese touch screen manufacturer
  • Advised China Investment Corporation on its $150 million investment in an energy company in the U.S.
  • Advised Goldman Sachs on the $563 million merger of China Water and Drinks Inc. with Heckmann Corporation
  • Advised Bank of New York on its $42 billion merger with Mellon Financial Corporation
  • Advised Rabobank on its $851 million acquisition of Mid-State Bank & Trust
  • Advised R.R. Donnelley & Sons Company on its $1.3 billion acquisition of Banta Corporation, an industry-leading provider of printing and print services and supply chain management services
  • Advised R.R. Donnelley & Sons Company on its acquisition of a leading producer of textbooks, testing and supplemental materials
  • Advised R.R. Donnelley & Sons Company on its acquisition of a leading provider of printing and print services
  • Advised Payless ShoeSource, Inc. on its $91 million acquisition of certain brand development, management and license partnerships
  • Advised Barclays Bank plc. on certain structured finance transactions